Homepage | Heart
WEBSep 2, 2024 · Heart. is an international journal from BMJ and BCS publishing important research and reviews in cardiovascular disease. Heart is an international peer reviewed journal that keeps cardiologists up to date with important research advances in cardiovascular disease. New scientific developments …
About - Heart
WEBAims and scope. Heart is an international peer reviewed journal that keeps cardiologists up to date with important research advances in cardiovascular disease. New scientific developments are highlighted in editorials and put in context with concise review articles. There is one free Editor’s Choice article in each issue, with open access ...
Authors - Heart
WEBAuthors. Time to first decision with review: 27 days (median) Total content views: 1.99 million. Impact factor: 5.1. Heart is an international peer reviewed journal that keeps cardiologists up to date with important research advances in cardiovascular disease. New scientific developments are highlighted in editorials and put in context with ...
Calcium and vitamin D supplement: right or wrong? - Heart
WEBIntuitively, one might think that supplementing vitamins and minerals would be the right thing to do especially in older and comorbid people. Every year, billions of dollars are spent in this belief.1 However, we may all be wrong. A present study in this journal demonstrates a significantly increased cardiovascular (CV) mortality in elderly patients supplementing calcium, be it with or without ...
Treating patients with ventricular ectopic beats | Heart
WEBVentricular ectopic beats (VEBs) are commonly seen in daily clinical practice. They are largely asymptomatic but can cause upsetting symptoms in some patients. In normal hearts, their occurrence is usually associated with no clinical significance. However, there are occasions where the presence of VEBs signifies a susceptibility towards more sinister arrhythmias, especially when heart disease ...
Global longitudinal strain: clinical use and prognostic ... - Heart
WEB### Learning objectives Non-invasive evaluation of left ventricular (LV) systolic function by echocardiography remains one of the most pivotal measures in clinical cardiology. Although conventionally quantified by means of LV ejection fraction (LVEF), it has become evident that this parameter is subject to a number of limitations. LVEF can be normal in the presence of impaired LV systolic ...
Bradyarrhythmias in patients with atrial fibrillation | Heart
WEBThe increasing burden of atrial fibrillation (AF) and significant morbidity/mortality associated with this arrhythmia encourage screening it in clinical practice, as recommended in current guidelines. It means opportunistic screening (in patients over 65 years) or systematic screening (in people above 75 years) by using clinical examination, followed by an ECG, 24-hour ECG monitoring or ...
Angina: contemporary diagnosis and management - Heart
WEB### Learning objectives Ischaemic heart disease (IHD) remains the leading global cause of death and lost life years in adults, notably in younger (<55 years) women.1 Angina pectoris (derived from the Latin verb ‘angere’ to strangle) is chest discomfort of cardiac origin. It is a common clinical manifestation of IHD with an estimated prevalence of 3%–4% in UK adults. There are over 250 ...
Diagnosis and treatment of pericarditis - Heart
WEBAcute pericarditis is the first attack of pericarditis, generally occurring with an acute onset of symptoms. Treatment of the episode generally lasts for 4–6 weeks, considering the attack dose and drug tapering. If the patient does not reach a remission and the disease lasts several weeks or months without a symptoms-free interval of 4–6 weeks, the term incessant pericarditis is adopted.
Update on management of atrial fibrillation in heart failure: a focus ...
WEBAtrial fibrillation is increasingly encountered in patients with heart failure. Both diseases have seen tremendous rises in incidence in recent years. In general, the treatment of atrial fibrillation is focused on relieving patients from atrial fibrillation-related symptoms and risk reduction for thromboembolism and the occurrence or worsening of heart failure. Symptomatic relief may be ...